HARTMANN in South Africa
Wound Care > Tips for treatment and care > Effective exudate management with PermaFoam cavity

Effective exudate management with PermaFoam cavity in the treatment of chronic wounds

Ulcerative conditions improve significantly when chronic wounds are treated with PermaFoam cavity foam dressing. An application study found that the purulent and oily coating on the wound is reduced by half.

PermaFoam cavity also reduces patient wound pain.

PermaFoam cavity also promotes formation of granulation and epithelial tissue. The attending physicians and the patients confirmed the good acceptability and tolerance of the foam dressing.

In an prospective, multi-centre and outpatient observational study involving 57 patients with predominantly chronic wounds, seven physicians (surgeons, dermatologists) and eight nursing services recorded the wound healing process with PermaFoam cavity.

The proper and consistent application of the foam dressing considerably improved the wound healing process.
While 54% of the wound was covered at the beginning of treatment, this proportion was reduced to 29% after three dressing changes.
At the same time, the percentage of wound area covered with granulation tissue increased from 41% to 59%, and the epithelial tissue area more than doubled from 4% to 11%. Due to the high absorption and retention capacity of PermaFoam cavity, the number of heavily exudating wounds was reduced from 32% to 11%. This had a positive impact on the wound environment. There were substantially fewer pathological findings such as edema, maceration, or erythema in the final examination than at the start of the study. During the application of PermaFoam cavity, the patients immediately experienced a reduction in pain. More than 45% of the patients had complained of severe or moderate wound pain at the beginning of the study, but only 26% at the end. 

Die konsequente Anwendung des Schaumverbandes verbesserte den Wundstatus der Patienten deutlich. Waren zu Beginn der Behandlung 54% der Wundfläche von Belägen bedeckt, reduzierte sich dieser Anteil nach drei Verbandwechseln auf 29%. Gleichzeitig stieg der Anteil des Wundgebietes mit Granulationsgewebe von 41% auf 59%, die Fläche des Epithelgewebes wuchs um mehr als das Doppelte von 4% auf 11%. Aufgrund seiner hohen Saugfähigkeit und Speicherkapazität verringerte PermaFoam cavity außerdem die Anzahl der stark exsudierenden Wunden von 32% auf 11%. Dies wiederum wirkte sich positiv auf die Wundumgebung aus. Pathologische Befunde wie Ödeme, Mazerationen oder Erytheme wurden bei der Abschlussuntersuchung deutlich seltener diagnostiziert als zu Beginn der Studie. Für die Patienten war bei der PermaFoam cavity-Anwendung der Rückgang der Schmerzen sofort spürbar. Klagten bei Beginn der Studie mehr als 45% über starke oder mäßige Wundschmerzen, waren es am Ende nur noch 26%.